1.0Drag Pharmahttps://dragpharma.cl/en/Marcia Cabrerahttps://dragpharma.cl/en/author/marcia-cabrera/rich600338<blockquote class="wp-embedded-content" data-secret="LbTupNBDaY"><a href="https://dragpharma.cl/en/producto/fatroximin/">Fatroximin®</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://dragpharma.cl/en/producto/fatroximin/embed/#?secret=LbTupNBDaY" width="600" height="338" title="“Fatroximin®” — Drag Pharma" data-secret="LbTupNBDaY" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); </script> https://dragpharma.cl/wp-content/uploads/2024/04/Fatroximin-2.jpg10001000FATROXIMIN,® an intramammary ointment, is indicated in cow drying for the therapy of existing subclinical mastitis, the prevention of possible infection during the dry period, and the prevention of acute postpartum mastitis, produced by Gram-positive (Streptococcus spp., Staphylococcus spp., Corynebacterium spp.) and Gram-negative (E. coli) microorganisms. It acts on the most common udder microbial species sensitive to Rifaximin, such as: Streptococcus agalatiae, Streptococcus dysgalactiae, Streptococcus uberis, Streptococcus faecalis, Staphylococcus aureus (including penicillin-resistant strains) and Staphylococcus epidermidis....Read more